AbbVie Inc. (ETR:4AB)
188.82
+0.54 (0.29%)
Mar 31, 2025, 1:49 PM CET
AbbVie Revenue
In the year 2024, AbbVie had annual revenue of $56.33B USD with 3.71% growth. AbbVie had revenue of $15.10B in the quarter ending December 31, 2024, with 5.60% growth.
Revenue
$56.33B
Revenue Growth
+3.71%
P/S Ratio
n/a
Revenue / Employee
$1.02M
Employees
55,000
Market Cap
335.26B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
AbbVie News
- 1 day ago - Top 4 defensive stocks to buy and hold ahead of Liberation Day - Invezz
- 2 days ago - Regulatory Condition Satisfied for License Agreement between AbbVie and Gubra - Wallstreet:Online
- 2 days ago - Regulatory Condition Satisfied for License Agreement between AbbVie and Gubra - Accesswire
- 2 days ago - Final Trades: PayPal, Meta, Abbvie and Snowflake - CNBC
- 3 days ago - AbbVie Vs. Sanofi: Which Is The Better Investment Right Now - Seeking Alpha
- 3 days ago - AbbVie shares rose after seven consecutive sessions of losses - Seeking Alpha
- 3 days ago - Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector. - Market Watch
- 5 days ago - AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025 - PRNewsWire